COSENTYX®


Solution for injection
scheduling status
S4
registration number
56/30.1/0243, 49/30.1/0233, 56/30.1/0242
What COSENTYX® contains
COSENTYX® 150 mg/1 mL solution for injection: Each 1,0 mL pre-filled syringe / pre-filled pen contains 150 mg secukinumab. COSENTYX® 300 mg/2 mL solution for injection: Each 2,0 mL pre-filled syringe or pre-filled pen contains 300 mg secukinumab.
other ingredients
Trehalose dihydrate, histidine/histidine hydrochloride monohydrate, methionine, polysorbate 80, water for injection.
Therapeutic classification
Immunosuppressants, interleukin inhibitors, ATC code: L04AC10.
© 2026 SAHPRA. ALL RIGHTS RESERVED